BACKGROUND: Until the mid of this century, 33% of the Western population will be > or = 65 years old. The percentage of patients being > or = 80 years old with today 5% will triple until 2050. Therefore, radiation oncologists must be familiar with special geriatric issues to meet the increasing demand for multidisciplinary cooperation and to offer useful and individual treatment concepts. PATIENTS AND METHODS: This review article will provide basic data on the definition, identification and treatment of geriatric cancer patients. RESULTS: The geriatric patient is defined by typical multimorbidity (15 items) and by age-related increased vulnerability. Best initial identification of geriatric patients will be provided by assessment including the Barthel Index evaluating self-care and activity in daily life, by the Mini-Mental Status Test that will address cognitive pattern, and by the Timed "Up&Go" Test for evaluation of mobility. As for chemotherapy, standard treatment was associated with increased toxicity, consequently, dose modifications and supportive treatment are of special importance. CONCLUSION: Geriatric cancer patients need to be identified by special assessment instruments. Due to increased toxicity following chemotherapy, supportive measures seem important. Radiation treatment as a noninvasive and outpatient-based treatment remains an important and preferable option.
BACKGROUND: Until the mid of this century, 33% of the Western population will be > or = 65 years old. The percentage of patients being > or = 80 years old with today 5% will triple until 2050. Therefore, radiation oncologists must be familiar with special geriatric issues to meet the increasing demand for multidisciplinary cooperation and to offer useful and individual treatment concepts. PATIENTS AND METHODS: This review article will provide basic data on the definition, identification and treatment of geriatric cancerpatients. RESULTS: The geriatric patient is defined by typical multimorbidity (15 items) and by age-related increased vulnerability. Best initial identification of geriatric patients will be provided by assessment including the Barthel Index evaluating self-care and activity in daily life, by the Mini-Mental Status Test that will address cognitive pattern, and by the Timed "Up&Go" Test for evaluation of mobility. As for chemotherapy, standard treatment was associated with increased toxicity, consequently, dose modifications and supportive treatment are of special importance. CONCLUSION: Geriatric cancerpatients need to be identified by special assessment instruments. Due to increased toxicity following chemotherapy, supportive measures seem important. Radiation treatment as a noninvasive and outpatient-based treatment remains an important and preferable option.
Authors: G Freyer; J-F Geay; S Touzet; J Provencal; B Weber; J-P Jacquin; G Ganem; N Tubiana-Mathieu; O Gisserot; E Pujade-Lauraine Journal: Ann Oncol Date: 2005-08-10 Impact factor: 32.976
Authors: Jochen Schuler; Christina Dückelmann; Wolfgang Beindl; Erika Prinz; Thomas Michalski; Max Pichler Journal: Wien Klin Wochenschr Date: 2008 Impact factor: 1.704
Authors: N P Nguyen; J Vock; A Chi; V Vinh-Hung; S Dutta; L Ewell; S Jang; M Betz; F Almeida; M Miller; R Davis; T Sroka; R P Vo; U Karlsson; P Vos Journal: Strahlenther Onkol Date: 2012-06-03 Impact factor: 3.621